Additionally, Th17 cells may also exert immunosuppressive functions via direct inhibition of tumor-specific CD8+ T effector cells [64], and development of IL-17+Foxp3+ regulatory T cells [65]. The gene discussed is CD8A; the disease is neoplasm.